Yahoo Web Search

Search results

    • Mainz Biomed Provides Half Year 2024 Corporate Update

      PharmiWeb· 1 day ago

      MAINZ, Germany – July 2, 2024 — Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, today reviewed its major accomplishments ...

    • FTSE 250 movers: Future surges on Jeffries upgrade

      ShareCast· 7 days ago

      Future surged on Wednesday as Jefferies upgraded the shares to ‘buy’ from ‘underperform’ and hiked the price target to 1,280p from 635p. The bank said "signs of inflection and Growth Acceleration ...